Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maxime Passard"'
Autor:
Frederick J. Raal, Geesje Dallinga-Thie, Livia Pisciotta, Maurizio Averna, Jorge Peter, Maxime Passard, Dirk J. Blom, Barbara Sjouke, Kees Hovingh, Alexis Guedon, Maria Laura Cossu, Aurélie Thedrez, Milco Ciccarese, Raul D. Santos, Mickael Croyal, Angelo B. Cefalù, Simon Prampart-Fauvet, Gilles Lambert, Paolo Pintus
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology
Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2016, 36 (8), pp.1647-1650. ⟨10.1161/ATVBAHA.116.307493⟩
Arteriosclerosis, thrombosis, and vascular biology, 36(8), 1647-1650. Lippincott Williams and Wilkins
Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2016, 36 (8), pp.1647-1650. ⟨10.1161/ATVBAHA.116.307493⟩
Arteriosclerosis, thrombosis, and vascular biology, 36(8), 1647-1650. Lippincott Williams and Wilkins
Objective— Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors lower low-density lipoprotein (LDL) cholesterol in the vast majority of patients with autosomal dominant familial hypercholesterolemia. Will PCSK9 inhibition with monoclona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ab1a2175c963c370de81866d875ef7e
https://doi.org/10.1161/atvbaha.116.307493
https://doi.org/10.1161/atvbaha.116.307493
Autor:
César Martín, Aitor Etxebarria, Asier Benito-Vicente, Mikaël Croyal, Aurélie Thedrez, Ana Margarida Medeiros, Mafalda Bourbon, Maxime Passard, Gilles Lambert, Ana Catarina Alves
Publikováno v:
Journal of the American College of Cardiology
Journal of the American College of Cardiology, Elsevier, 2015, 66 (19), pp.2152-2154. ⟨10.1016/j.jacc.2015.08.871⟩
Journal of the American College of Cardiology, Elsevier, 2015, 66 (19), pp.2152-2154. ⟨10.1016/j.jacc.2015.08.871⟩
Letter Gain of function (GOF) mutations in proprotein convertase subtilisin kexin type 9 (PCSK9) are a rare cause of familial hypercholesterolemia (FH). We identified a child with a clinical diagnosis of FH with 2 novel putative PCSK9 GOF missense va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c4909d056f8d616fe1604a0f0a806b4
https://hal.archives-ouvertes.fr/hal-02429690
https://hal.archives-ouvertes.fr/hal-02429690
Autor:
Anne-Charlotte de Gouville, Maud Chétiveaux, Maxime Passard, Khadija Ouguerram, Gilles Lambert, E. Nobecourt, Véronique Ferchaud-Roucher, Mikaël Croyal, Stéphanie Billon-Crossouard, Michel Krempf
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 35(9)
Objective— To determine the mechanisms by which extended-release nicotinic acid reduces circulating lipoprotein (a) concentrations in hypertriglyceridemic patients. Approach and Results— Eight nondiabetic, obese male subjects (aged 48±12 years;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef866d211ced8cbd270a04fe4ec293f
https://pubmed.ncbi.nlm.nih.gov/26160958
https://pubmed.ncbi.nlm.nih.gov/26160958
Autor:
William J. Sasiela, Uwe Schwahn, Francine Petrides, Dirk J. Blom, Maxime Passard, Aurélie Thedrez, Gilles Lambert, Kerry-Anne Rye, Viktoria Gusarova, A. David Marais, Mathias Chatelais
Publikováno v:
Journal of the American College of Cardiology. 64(21):2299-2300
Proprotein convertase subtilisin kexin type-9 (PCSK9) inhibition using monoclonal antibodies (mAbs) lowers low-density lipoprotein cholesterol (LDL-C) by >50% in heterozygous familial hypercholesterolemia (HeFH) and non-FH dyslipidemic individuals [(
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab5a4ddd0aa31c56ca2c674ae55fbb24